For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Revolution Treatment Arm | This is a single-arm study. All eligible and participating patients will be treated wit the Revolution™ Peripheral Atherectomy System. Revolution™ Peripheral Atherectomy System: The Rex Medical Revolution™ Peripheral Atherectomy System is a minimally invasive catheter-based atherectomy system used to treat patients who suffer from PAD. This system is designed to treat a broad range of plaque types both above and below the knee and may address many of the limitations associated with existing treatment options. | 3 | None | 26 | 121 | 78 | 121 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Clinically Driven TLR | SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| Major target limb amputation | SYSTEMATIC_ASSESSMENT | Surgical and medical procedures | None | View |
| Perforation of target vessel | SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| Distal embolization | SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| All-cause mortality | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Blood and lymphatic system disorders | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Cardiac disorders | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Endocrine disorders | SYSTEMATIC_ASSESSMENT | Endocrine disorders | None | View |
| Eye disorders | SYSTEMATIC_ASSESSMENT | Eye disorders | None | View |
| Gastrointestinal disorders | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Injury, poisoning and procedural complications | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | None | View |
| General disorders and administration site conditions | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Hepatobiliary disorders | SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | None | View |
| Infections and infestations | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Investigations | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| Metabolism and nutrition disorders | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| Musculoskeletal and connective tissue disorders | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| Neoplasms benign, malignant and unspecified (incl cysts and polyps) | SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | None | View |
| Nervous system disorders | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Product issues | SYSTEMATIC_ASSESSMENT | Product Issues | None | View |
| Psychiatric disorders | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | None | View |
| Renal and urinary disorders | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Reproductive system and breast disorders | SYSTEMATIC_ASSESSMENT | Reproductive system and breast disorders | None | View |
| Respiratory, thoracic and mediastinal disorders | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Skin and subcutaneous tissue disorders | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Surgical and medical procedures | SYSTEMATIC_ASSESSMENT | Surgical and medical procedures | None | View |
| Vascular disorders | SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |